Long COVID vs ME/CFS: Symptoms, Mechanisms, and Post-Viral Insights (2026)
Long COVID vs ME/CFS: Understanding Post-Viral Syndromes Long COVID (post-acute sequelae of SARS-CoV-2 infection, PASC) and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) are two post-viral syndromes that share overlapping symptoms such as fatigue, brain fog, and post-exertional malaise. However, recent studies highlight unique mechanistic and clinical differences, particularly in inflammation, endothelial injury, and energy metabolism. This article provides an evidence-based comparison, with links to related topics on spike protein persistence, endothelial dysfunction, mitochondrial dysfunction & NAD⁺, and nutraceutical interventions. Epidemiology: Who Gets Long COVID vs ME/CFS? Key Points: Long COVID affects ~10–30% of COVID survivors (WHO, 2023) ME/CFS affects ~0.2–0.5% of the population (Jason et al., 2021) Long COVID can affect all age groups, peak 40–60; ME/CFS peaks 30–50 Both show female predominance; stronger in ME/CFS Related: Long COVID overview Clinic...